Labor Day is in the rearview mirror, kids are back to school, and a squall of pumpkin spice is upon us. It's that time again to prepare for the equally inevitable respiratory virus season with annual vaccines.

With fervent anti-vaccine activist Robert F. Kennedy Jr. as the country's top health official, it might seem like the rollout of this year's shots could be a disaster. For instance, one of Kennedy's first actions as health secretary last year was to obliterate an ad campaign for flu shots amid a particularly deadly flu season. As we head into this fall, the Centers for Disease Control and Prevention's vaccine advisory committee—which normally sets vaccination recommendations and insurance coverage for the shots—is nonfunctioning. A federal judge ruled in March that the anti-vaccine allies Kennedy installed on the panel were illegally appointed and unfit to serve. All their changes to vaccine policy have been temporarily voided. And meanwhile, Kennedy spent last week trying to obscure the number of babies who died from measles so far this year (it was two, including a newborn).

Big picture

Despite all of that, the fall vaccine effort is looking like it will likely be somewhat smooth, potentially unremarkable even. The Food and Drug Administration has approved updated flu and COVID-19 shots for this season. Those shots have already begun arriving at pharmacies—in case your pharmacy hasn't already sent you multiple texts and reminders. While there are still some snags for access, it seems like it will be a lot like last year's fall vaccine rollout.

Read full article

Comments

Despite significant drama from Trump officials this year, the Food and Drug Administration has for the first time approved a flu vaccine that uses mRNA technology.

On Thursday, vaccine maker Moderna announced that its flu shot, mRNA-1010, aka mFLUSIVA, had earned approval for use in all adults ages 50 and up. The approval announcement follows a unanimous vote by FDA advisors in June to approve the vaccine. That vote was based on its superior efficacy to existing seasonal flu shots and a good safety record demonstrated in trials that included nearly 44,000 people. After that vote, the FDA set a goal of August 5 for a decision on the vaccine's fate.

While the unanimous support from FDA advisors boded well for Moderna's shot, the overall path to approval was treacherous and uncertain, even until the end. For one thing, current Health Secretary Robert F. Kennedy Jr. is a well-established anti-vaccine advocate who has worked diligently in his time in office to thwart vaccinations. One of his first acts as health secretary was canceling a federal campaign to encourage people to get flu shots in the midst of a bad flu season—despite the fact that the Centers for Disease Control and Prevention had already paid for the campaign and the flu season was killing relatively high numbers of children.

Read full article

Comments